Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy

October 31, 2022 updated by: Kao-Ping Chua, University of Michigan
This study will evaluate whether lowering the default number of doses for opioid prescriptions written in an electronic health record system can decrease opioid prescribing without causing unintended consequences such as worsened pain control.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

198

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • The University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 25 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adolescents and young adults aged 12-25 years undergoing tonsillectomy at C.S. Mott Hospital, University Hospital, Brighton Center for Specialty Care, or Livonia Center for Specialty Care from October 2019-July 2021, excluding April-May 2020 (owing to suspension of elective procedures due to COVID-19).
  • Surgeon belongs to the Department of Otolaryngology at the University of Michigan Medical School
  • Patients are not any of the following: patients living in foster care or with a legal guardian, patients with medical complexity or developmental delays, non-English speaking patients, patients with recent suicidal ideation documented in their chart, or patients undergoing emergent tonsillectomy.

Exclusion Criteria:

  • Patients with prescription opioid use prior to surgery
  • Patients undergoing additional procedures at the same time as tonsillectomy (other than minor procedures such as tympanostomy tube placement)
  • Patients enrolled in another study
  • Patients who are not prescribed opioids post-operatively at discharge
  • Patients who are enrolled in the Michigan Pain-control Optimization Pathway (M-POP), which includes education about pain management and a small initial opioid prescription
  • Patients with hospitalization with length of stay > 1 day after surgery
  • Patients who decline to enroll
  • Additional exclusion criteria for secondary analysis: Patients who do not complete the baseline and post-operative day 14 surveys

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Default setting intervention
The arm will include all patients undergoing tonsillectomy at C.S. Mott Hospital by a pediatric otolaryngology faculty member at the University of Michigan.
The new default settings will be implemented only for patients in the experimental arm.
No Intervention: No Intervention: Control (Usual Care)
The arm will include all patients undergoing tonsillectomy at University Hospital, Brighton Center for Specialty Care, or Livonia Center for Specialty Care by a general otolaryngology faculty member at the University of Michigan.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Doses in the Initial Discharge Opioid Prescription
Time Frame: Day of discharge, approximately 1 day
Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed. Number of doses are calculated from the electronic health record.
Day of discharge, approximately 1 day
Proportion of Patients for Whom the Number of Doses in the Discharge Opioid Prescription Equals the Number of Doses in the New Default Settings
Time Frame: Day of discharge, approximately 1 day

The new default settings called for 12 doses in the discharge prescription.

This measure assesses the proportion of participants with 12 doses in the discharge prescription, regardless of which arm they were in.

Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed. Number of doses are calculated from the electronic health record.

Day of discharge, approximately 1 day
Proportion of Participants Who Had at Least One Opioid Prescription Refill From University of Michigan During the Two Weeks After Surgery
Time Frame: Day 14
Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed. Number of doses are calculated from the electronic health record.
Day 14
Proportion of Patients Who Visited or Saw a University of Michigan Provider Due to Pain During the Two Weeks After Surgery
Time Frame: Day 14
Detailed in electronic health record. Excludes emergency department visits and hospitalizations for pain.
Day 14
Proportion of Patients With at Least One Emergency Department and/or Hospitalization at University of Michigan for Pain During the Two Weeks After Surgery
Time Frame: Day 14
Detailed in electronic health record
Day 14

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Satisfaction Score on Pain Control During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14

Participants were surveyed on Day 14 and asked to report level of satisfaction with pain control since their surgery.

Pain control satisfaction is on a scale of 1-10 with higher scores indicating higher satisfaction

Day 14
Proportion of Patients Who Reported That Their Pain Was Well-controlled as Measured by the Post-operative Survey.
Time Frame: Day 14
Day 14
Proportion of Patients Whose Overall Pain Control Was Rated as Much Worse or Worse Than Expected as Measured by the Post-operative Survey.
Time Frame: Day 14

Survey was comprised of 5 options:

  • Much worse than you expected
  • Worse than you expected
  • About what you expected
  • Better than you expected
  • Much better than you expected
Day 14
Proportion of Patients Whose Pain Has Resolved by Day 14 After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Survey asked participant on what day pain had resolved. If participants indicated pain had resolved by Day 14, then they were coded as 1, and 0 otherwise.
Day 14
Pain in the Throat and/or Mouth Over the Past 7 Days at Its Worst as Measured by the Post-operative Survey.
Time Frame: Day 14
Pain control is on a scale of 0-10 with higher scores indicating more pain.
Day 14
Pain in the Throat and/or Mouth Over the Past 7 Days on Average as Measured by the Post-operative Survey.
Time Frame: Day 14
Pain control is on a scale of 0-10 with higher scores indicating worse pain.
Day 14
Proportion of Patients With Leftover Doses of Opioids as Measured by the Post-operative Survey.
Time Frame: Day 14
Participants who answered 'No' to the following question: Did you take all of the opioid pain medications that were prescribed to you during the two weeks after surgery?
Day 14
Number of Opioid Doses Taken During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Patients were asked to report the number of instances in which they used opioids prescribed to them.
Day 14
Proportion of Patients Who Misused Opioids Prescribed to Others at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Includes any use of opioids prescribed to others
Day 14
Proportion of Patients Who Misused Opioids Prescribed to Them at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Includes taking one's own opioids in greater amounts, more often, or longer than directed by a doctor.
Day 14
Patient Health Questionnaire 8-item (PHQ-8) Score (Depression) as Measured by the Post-operative Survey.
Time Frame: Day 14
This is an 8-item self-report scale, all items are rated on a score of 0-3, for a total range of 0-24. Higher scores indicate more depressive symptoms
Day 14
Patient-Reported Outcomes Measurement Information System (PROMIS)- Pediatric Anxiety - Short Form 8a Score as Measured by the Post-operative Survey.
Time Frame: Day 14
This measure is 8 items each scored from 1 to 5 points, with the lowest possible raw score being 8 and the highest possible raw score being 40. Higher scores indicate greater anxiety,
Day 14
Patient-Reported Outcomes Measurement Information System (PROMIS)- Sleep Disturbance - Short Form 4a Score as Measured by the Post-operative Survey.
Time Frame: Day 14
This measure is 4 items each scored from 1 to 5 points, with the lowest possible raw score being 8 and the highest possible raw score being 40. Higher scores indicate greater sleep disturbance, i.e. worse sleep.
Day 14
Proportion of Patients Who Saw Their Primary Care Doctor (or a Colleague) in the Office Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Day 14
Proportion of Patients Who Visited a Retail Clinic Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Day 14
Proportion of Patients Who Visited an Urgent Care Center Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Day 14
Proportion of Patients Who Visited an Emergency Department and/or Were Hospitalized Due to Poorly Controlled Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
Day 14
Proportion of Patients With Leftover Doses Who Disposed of Them
Time Frame: 14 Days
Proportion of patients with leftover doses who disposed of them
14 Days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kao-Ping Chua, University of Michigan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

July 31, 2021

Study Completion (Actual)

July 31, 2021

Study Registration Dates

First Submitted

August 22, 2019

First Submitted That Met QC Criteria

August 22, 2019

First Posted (Actual)

August 26, 2019

Study Record Updates

Last Update Posted (Actual)

November 1, 2022

Last Update Submitted That Met QC Criteria

October 31, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00159821
  • 1K08DA048110 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tonsillectomy

Clinical Trials on Default setting intervention

Subscribe